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1. Introduction 
Human and Simian Immunodeficiency Viruses (HIV and SIV) are the etiological agents of 
the Acquired Immunodeficiency Syndrome (AIDS) in humans and the Simian AIDS (SAIDS) 
in macaques, respectively. HIVs and SIVs are members of the Retroviridae family, Lentivirus 
genera, and are considered complex retroviruses since its genome organization predicts the 
presence of at least 6 open reading frames (ORFs) in addition to the main Gag, Pol and Env 
ORFs present in the genomes of all retroviruses. These additional ORFs code for both 
regulatory (Tat and Rev) and accessory (Nef, Vif, Vpr, Vpu and Vpx) viral proteins and are 
all organized from the 5’ half of the genome in a way that overlap both with each other and 
with the Pol and Env ORFs and the non-coding 3’ Long Terminal Repeat (LTR) region 
(Figure 1). To ensure its expression and to achieve an optimal production of the viral 
progeny, complex mechanisms have evolved in these viruses that tightly control the 
expression of these ORFs during the viral replication cycle. The existence of such a number 
of viral proteins in addition to the viral structural (Gag and Env) and enzymatic (Pol) 
proteins allows the virus to explore new mechanisms to control the different steps of the 
replication cycle and to avoid the host cell defense. In this chapter we shall review the 
different steps of the HIV and SIV replication cycle with emphasis in the role taken by the 
viral accessory protein Nef, in both subverting the host cell machinery and influencing the 
function and activation of viral structural and enzymatic proteins in order to optimize viral 
progeny production as well as in evading the host cell defenses. 
Lentiviral accessory proteins Vif, Vpr, Vpu and Nef were classically regarded as non-
essential for virus production and/or infectivity since laboratory adapted HIV strains 
lacking the expression of these proteins could still replicate to several levels (Adachi et al., 
1991). Since then, several studies demonstrated the crucial importance of these proteins to 
the efficient replication, infectivity and spread of both HIV and SIV (Kirchhoff, 2010). 
Vif (Aguiar and Peterlin, 2008) and Vpu (Adachi et al., 1991) have now been 
acknowledged as crucial viral factors that counteract the host cell innate defense. Vif 
interacts and prompts the degradation of a family of cytidine deaminases DNA/RNA 
editing enzymes, known as Apoliprotein B mRNA-editing Enzymes (APOBECs), that 
otherwise would inhibit HIV and SIV replication by causing hypermutation of nascent 
www.intechopen.com
  
HIV and AIDS – Updates on Biology, Immunology, Epidemiology and Treatment Strategies 
 
4 
retroviral genomes by deamination of cytidine residues (Aguiar and Peterlin, 2008). Vpu 
is a type-1 membrane associated protein that was first demonstrated to be involved in the 
downmodulation of the Cluster of Differentiation Antigen 4 (CD4) receptor from the 
infected cell surface by a mechanism of inducing the proteassomal degradation of the 
newly synthesized CD4 molecules in the Endoplasmic Reticulum (ER) (Schubert et al., 
1998; Willey et al., 1992). Expression of Vpu is restricted to HIV-1 and a subset of SIV 
linages related to HIV-1. In HIV-2 and the related SIVsooty mangabey (SIVsm) linage, 
which lack the vpu gene, the cytoplasmic domain of the viral envelope protein gp41 
mimicks this function of Vpu (Bour et al., 1996). For a long time it was considered to be 
the mechanism by which Vpu lead to an increase in HIV infectivity. Recently, however, it 
was demonstrated that Vpu in HIV-1 and related SIVs increases viral particle release from 
the infected cells by removing an Interferon-regulated protein (BST-2 or Theterin) from 
the surface of the infected cells, that otherwise would function as a host restriction factor 
inhibiting viral release (Neil et al., 2006; Neil et al., 2007; Neil et al., 2008). 
Nef, the misnamed Negative Factor, is a myristoylated 27-35 kDa protein encoded at the far 
3’end of the primate lentiviral genome (Figure 1). Nef is post-translationally modified by the 
addition of a myristic acid at glycine residue at amino acid position 2 (G2) on the N-terminal 
of the protein. This modification is required for the association of Nef to cellular 
membranes. Another post-translational modification in Nef is its cleavage by the virally 
encoded Protease (PR), which will be discussed further. The terciary structure of the Nef 
protein predicts an anchor domain encompassing the first 57 amino acids from the N-
terminal, a highly structured central core domain encompassing amino acid residues 58-147, 
and a unstructures flexible C-terminal domain encompassing amino acid residues 148-180 
which is commonly named C-terminal flexible-loop (Geyer et al., 2001)  
Nef was first described as a negative regulator of the HIV-1 replication since in the absence 
of its expression levels of transcription from the viral LTR and viral replication were 
reported to be higher than in cells infected with the Nef positive virus counterpart (Ahmad 
and Venkatesan, 1988; Cheng-Mayer et al., 1989). Soon it was demonstrated that in fact the 
absence of Nef expression has a negative effect for virus spread in HIV-1-infected CD4 (+) 
cell cultures (Cheng-Mayer et al., 1989; Hammes et al., 1989; Kim et al., 1989; Lama et al., 
1999; Ross et al., 1999). Moreover, evidences accumulated that the lack of Nef expression 
even in CD4 (-) cell cultures leads to reduction in the infectivity of the viral progeny 
(Chowers et al., 1995; Goldsmith et al., 1995). The effect of the Nef protein in virus infectivity 
is direct and specific since it can be rescued by providing Nef in trans to the virus producer 
cell (Miller et al., 1995; Pandori et al., 1996). The increase in virus infectivity by Nef is well-
conserved amonsgst alleles from both HIVs and SIVs and can vary from 4-40-fold increase 
depending on the nef allele and the cell system being assayed. Nowdays, the increase in viral 
infectivity by Nef is the only consensus phenotype recognized for this primate lentiviral 
accessory protein. 
The definitive proof of the crucial importance of Nef for HIV and SIV infections came from 
studies demonstrating that the disruption or the absence of the nef gene in both viruses was 
related to a slower or non-progression to AIDS in naturally infected humans and 
experimentally infected rhesus macaques, respectively (Daniel et al., 1992; Deacon et al., 
1995; Kirchhoff et al., 1995). It was clearly demonstrated in these studies that in the absence 
of Nef expression infection with these viruses failed to mantain high levels of viremia and to 
progress to AIDS, defining Nef as a key factor for the pathogenesis of primate lentiviruses. 
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As soon as it was demonstrated that Nef has an important role for HIV and SIV infections 
several studies were conducted to ellucidate the mechanism by which this protein 
influences viral replication. The several functions described for Nef in the last two decades 
are reviewed in the sections bellow.  
 
 
Fig. 1. Representative genomic organization of the provirus of the primate lentiviruses. The 
main (gag, pol and env); regulatory (tat and rev); and accessory (vif, vpr, vpu and nef) ORFs are 
represented by horizontal lines. The black squares represent the LTRs present at the 5’and 3’ 
extremities of the genome. The two exons of tat and rev are conected by angled lines. Note 
the extensive overlap of the structural, regulatory and accessory ORFs from the 3’half of the 
genome. 
2. The classical functions of the HIV and SIV Nef proteins 
2.1 Downmodulation of CD4 and MHC-I  
The Nef protein from HIV and SIV have multiple functions and achieve its biochemical 
effects upon interactions with cellular components. Over thirty putative Nef targets have 
already been described. One of the first proteins that have been found associated with Nef is 
the human transmembrane CD4, which is downregulated from the cell surface by Nef 
(Garcia and Miller, 1991). Moreover, Nef also down-regulates other cell-surface proteins, as 
the major histocompatibility complex class I (MHC-I) molecules (Greenberg et al., 1998b; 
Swigut et al., 2000).  
Observations from naturally HIV-1-infected individuals indicated that Nef functions on 
downmodulation of CD4 and MHC-I could be related to the pathogenesis of AIDS (Carl et 
al., 2001; Tobiume et al., 2002), however the real contribution of these functions still needs to 
be demonstrated (Crotti et al., 2006). The motifs in Nef that mediate CD4 downregulation 
were considered critical for SIVmac replication in rhesus macaques, however MHC-I 
downregulation by Nef is not sufficient for optimal virulence of SIVmac early in infection 
(Iafrate et al., 2000; Lang et al., 1997; Schindler et al., 2004). Moreover, the solely importance 
of the CD4 downmodulation for SIVmac pathogenesis in experimental models has been 
challenged (Jesus da Costa et al., 2009). The mechanisms by which Nef interferes with CD4 
and MHC-I expression are described below. 
CD4 is a type I integral membrane glycoprotein expressed primarily on T cells, thymocytes, 
and cells of the macrophage–monocyte lineage (Littman, 1987). CD4 is required for T-cell 
activation by the TCR signaling pathway and serves as the primary receptor for HIV and 
SIV. However, its continuous presence on the surface of HIV/SIV infected cell after viral 
entry is problematic for several reasons. First, because of their capacity to form complexes, 
co-expression of CD4 and the viral envelope protein gp120 disrupts the trafficking of both 
proteins (Lama et al., 1999; Ross et al., 1999). In addition, the presence of CD4 on the cell 
membrane reduces the ability of the newly formed particles to be properly released from the 
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infected cell therefore reducing viral infectivity (Cortes et al., 2002; Lama et al., 1999). 
Finally, decreasing the number of viral receptors on the surface of an infected cell seems to 
prevent reinfection by HIV/SIV particles (the so-called superinfection) (Le Guern and Levy, 
1992; Michel et al., 2005). 
Nef reduces the steady-state levels of CD4 by several proposed models based on a premise: 
Nef binds to the cytoplasmatic tail and promotes the endocytosis of CD4 from the cell 
surface, which in turn results in CD4 degradation in lysosomes. Thus myristoylation of Nef, 
which is necessary for its membrane localization, is crucial for the downmodulation of CD4 
(Bentham et al., 2003). For binding, a cluster of residues in the N-terminal half of HIV-1 Nef 
recognizes a dileucine motif within the cytoplasmatic tail of CD4 (Leu-413-414) exposed 
only when the serine residues in CD4 are phosphorylated (Aiken et al., 1994; Bentham et al., 
2003; Pitcher et al., 1999). Subsequently, Nef acts as connector between mature CD4 and 
components of clathrin-dependent trafficking pathways at the cell surface (and to a lesser 
degree in the Golgi apparatus). For this purpose, Nef bridges the CD4 cytoplasmic tail with 
the adaptor protein complex of endosomal clathrin-coated pits (CCPs), thereby triggering 
the formation of CD4-specific endocytic vesicles, and the catalytic unit of the vacuolar 
proton pump v-ATPase (Bresnahan et al., 1998; Foti et al., 1997; Lu et al., 1998; Mandic et al., 
2001; Mangasarian et al., 1997; Piguet et al., 1998). Furthermore, to target CD4 for lysosomal 
degradation Nef connects the receptor with the ǃ subunit of the COP-I coatomer in 
endosomes, diverting Nef-bound CD4 molecules from a recycling to a degradation pathway 
(Piguet et al., 1999).  
Another conserved function of Nef  across HIV/SIV is the disruption of the transport of 
MHC-I to the cell surface in infected T cells to avoid immune recognition by cytotoxic T 
lymphocytes (CTLs) (Greenberg et al., 1998b; Swigut et al., 2000). The pathway is initiated 
by Nef binding to the phosphorin acidic cluster sorting protein-2 (PACS-2), which controls 
the endosome-to-Golgi trafficking of cytosolic sorting proteins, then targeting Nef and its 
cargo to the perinuclear region to bind and activate Scr family kinase (SFK). This Nef-SFK 
complex then phosphorylates ZAP-70 (Syk in monocytes and heterologous cells) on 
tyrosine, enabling ZAP-70-SFK complex to bind the SH2 domain of Phosphatidyl Inositol 3 
Kinase (PI3K) (Swann et al., 2001). MHC-I is constitutively internalized and recycled via a 
GTPase ADP ribosylation factor 6 (ARF6) pathway. This multi-kinase complex triggers 
internalization of cell-surface MHC-I through a clathrin-independent, ARF6-dependent 
pathway, which connects vesicle trafficking with actin cytoskeletal rearrangement (Atkins et 
al., 2008; Blagoveshchenskaya et al., 2002; Hung et al., 2007).  
Other authors showed evidence that Nef acts early in the secretory pathway to redirect 
MHC-I from the trans-Golgi network (TGN) to the endolysosomal pathway known as 
anteretrograde trafficking. Nef directs the MHC-I into the trans-Golgi compartment through 
association with clathrin adaptor protein complex (AP-1), thereby sorting these proteins into 
specific clathrin-coated transport vesicles addressed to the endolysosomal pathway 
(Greenberg et al., 1998b), moreover MHC-I molecules in the trans-Golgi are probably 
targeted for degradation. Consistent with this model, RNA interference (RNAi) against AP-1 
blocks Nef-mediated disruption of MHC-1. AP-1 was also demonstrated to co-precipitate 
with MHC-I and Nef in HIV-infected primary T cells (Roeth et al., 2004). Therefore, Nef 
binds to the MHC-I and stabilizes the interaction of a tyrosine in the cytoplasmic tail of 
MHC-I with the natural tyrosine-binding pocket in AP-1 (Wonderlich et al., 2008). Nef 
targets early types of MHC-I molecules in the ER by preferentially binding 
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hypophosphorylated cytoplasmic tails, thus preventing completion of the secretory 
pathway that would finally provide an antigen-presenting receptor on the cell surface to 
activate killing of the virus-infected cell (Kasper et al., 2005). 
These models may not be mutually exclusive, a recent work shows that Nef simultaneously 
uses both antiretrograde and retrograde trafficking to down-regulate human leukocyte 
antigen class I (HLA-I) in the peripheral blood mononuclear cells and HeLa cells (Yi et al., 
2010).  Besides, another report used a small molecule to disrupt Nef-SFK binding and found 
that Nef orchestrates a highly regulated molecular program consisting of sequential use of 
signaling followed by stoichiometric modes to evade immune surveillance (Dikeakos et al., 
2010). 
Human MHC-I main function is to regulate the development of an immune response. HLA-
I genes include HLA-A, B, and C (Tripathi and Agrawal, 2007) and its removal from the cell 
surface increases the potential susceptibility of infected cells to elimination by natural killer 
cells (NK). Nef downregulates highly polymorphic HLA-A and -B molecules as a 
mechanism of HIV-1 immune evasion, but not HLA-C or -E molecules which frequently 
serve as ligands to inhibit the activation of NK cells (Lanier, 2005). This selection is broadly 
conserved between SIV (smm/mac) and HIV-2 Nef alleles (DeGottardi et al., 2008). 
Moreover, differences in HLA downmodulation by Nef are based on amino acid 
modifications in HLA cytoplasmic domains, which implies that diverse properties of Nef 
are required to achieve the simultaneous evasion of the CTL and natural killer cell 
surveillance by HIV (DeGottardi et al., 2008; Lanier, 2005). 
Nef is sufficiently adaptable to maintain downregulation of MHC-I and CD4 as a two 
independent functions and neither activity is optimized by the transmission event, despite 
the changing in immune pressure associated with sexual transmission (Noviello et al., 2007). 
In conclusion, the dramatic reduction of CD4 and MHCI expression in infected cells 
achieved by Nef seems to be in some degree important for the successful establishment of 
infection in a new host.  
2.2 Downmodulation of MHC-II 
In many ways Nef act in order to disrupt immune communication. Besides 
downmodulating MHC-I, CD80 and CD86, (Chaudhry et al., 2005; Greenberg et al., 1998a), 
Nef also interfere with MHC-II surface expression. However, for this surface marker, 
downmodulation is achieved by many mechanisms: i) Nef causes endocytosis of mature 
peptide-loaded MHC-II from the cell surface; ii) Nef can induce accumulation of immature 
MHC-II associated with the invariant chain (Ii) on the cell surface; iii) Nef reduces the rate of 
MHC-II delivery to the cell surface (Chaudhry et al., 2009; Stumptner-Cuvelette et al., 2001). 
MHC-II depends extensively on the endocytic machinery in order to be properly mounted 
on the cell surface. After its translocation to the endoplasmatic reticulum a mechanism is 
needed in order to prevent association with its own peptides. This is achieved by MHC-II 
association with the Ii, which blocks the MHC-II peptide cleft, forming the immature MHC-
II complex. This immature MHC-II complex exits the ER and move through the Golgi 
apparatus. Finally, vesicles containing immature MHC-II fuse to MIIC vesicles, a specialized 
MHC-II peptide-loading compartment containing all the components needed to Ii 
degradation and foreign peptide loading onto the MHC-II cleft. The mature MHC-II is then 
directed to the cell membrane where interaction with the TCR of a CD4+ cell can happen. A 
fraction of immature MHC-II travels to the plasma membrane and is subsequently 
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internalized and directed to MIIC vesicles. A similar endocytosis mechanism was described 
to recycle mature MHC-II from the cell surface (Reid and Watts, 1992). 
Nef selectively distinguishes between mature and immature MHC-II. While induces a two-
fold reduction of peptide-loaded MHC-II from the cell surface, Nef induces a 15-fold more 
accumulation of immature MHC-II complexes composed of Ii, alpha and beta MHC-II 
chains. The motifs in Nef needed for one function or another are different. While for mature 
MHC-II endocytosis, the acidic motif EEEE65 is important, for upregulation of immature 
MHC-II WL57,58 motif is required. For both of them the poliproline (PxxP) and dileucine 
(LL164) motifs in Nef are required. The amount of Nef needed also vary depending on the 
phenomena. It was observed in transient expression experiments that even small quantities 
of Nef were enough for Ii upregulation, while for MHC-II downmodulation high expression 
of Nef was required. Of note, those high levels of Nef expression were considered 
physiologically relevant, as experiments using HIV infected cells showed quantities of Nef 
similar to that seen on super expression experiments (Stumptner-Cuvelette et al., 2001). 
Nef also acts slowing the delivery rate of newly synthesized MHC-II molecules to the plasma 
membrane, however this molecular mechanism is less explored (Chaudhry et al., 2009). 
Loss of cell surface MHC-II induced by Nef is observed during HIV-1 host cell infection. In 
the presence of Nef, mature MHC-II are found at high levels in intracellular lysossomal 
compartments, marked with Lamp-1, while delivery of immature MHC-II to the 
endolysossomal compartment is impaired. MHC-II Nef-mediated endocytosis was 
described as dependent on Rab5, Lyst, cholesterol and Phosphatidyl Inositol Kinases, and 
dispenses Dynamin 2 (Dyn2) (Chaudhry et al., 2009). 
This downmodulation of mature and upregulation of immature MHC-II is a function 
conserved in many nef alleles from HIV-1/2 and SIVs. Contrary to what is seen in MHCI 
downmodulation, Nef activity on MHC-II and Ii do not change significantly during the 
stages of infection. Of note, the strong Ii upregulation observed in the presence of wild type 
Nef is lost in some nef alleles derived from Long-term infected HIV-1 patients which do not 
progress to AIDS, suggesting that this feature of Nef may contribute to immune evasion 
(Schindler et al., 2003). 
Although Nef has been described to directly bind to the citoplasmatic tail of many receptors 
that it modulates (Chaudhry et al., 2005), there is still no evidence that it can bind MHC-II, 
suggesting that Nef might interact with proteins involved in the physiological turnover 
pathways of this surface marker, disrupting the natural balance of MHC-II surface expression. 
The model postulates that recycling MHC-II enters sorting endossomes for a decision on 
whether they will be recycled back to surface or not, which is where Nef intervene and reroute 
them to the Golgi apparatus. This model takes advantage of the observation that mature 
MHC-II is short-lived on the cell surface and thus, Nef subversive action on the endocytic 
program responsible for the removal of MHC-II is plausible (Chaudhry et al., 2009). 
Another model has been proposed for Ii upregulation. In this simpler model, Nef would 
increase Ii surface expression by competing for the endocytic machinery. More specifically, 
the dileucine motif in Nef would tritate AP-2, the adaptor protein responsible for Ii 
endocytosis (Mitchell et al., 2008). Although elegant, this model encounters some conflicting 
data, showing that a small amount of Nef is able to induce strong accumulation of Ii. Also, 
other receptors that depend on AP-2 for its endocytosis, such as the Transferrin receptor, are 
not upregulated by Nef (Schindler et al., 2003). Nevertheless, this could be another 
mechanism used for Ii upregulation and still cannot be discarded. 
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2.3 Cellular activation by Nef 
It is now clear that Nef is capable of mimicking transcriptional programs in order to 
manipulate the cell activation status in a way that favors HIV pathogenesis in a myriad of 
ways. The Nef protein can deliver antiapoptotic signals to the infected cells in order to 
sustain a prolonged infection, create a viral reservoir, or increase the number of permissive 
cells for viral infection (Mahlknecht et al., 2000). In a contrary fashion, it can stimulate 
apoptosis in bystander CD8+ T lymphocytes to evade immune response (Xu et al., 1999). In 
any case, the cell reprogramming induced by Nef is not only limited to manipulation of 
apoptosis. It also includes the activation or suppression of cell signaling pathways 
(Mahlknecht et al., 2000; Mangino et al., 2007; Percario et al., 2003; Varin et al., 2003). 
Although the effects of Nef sometimes seem contradictory it must be stressed out that its 
functions are the product of many protein-protein interactions that can take place during 
different steps of the viral replication cycle in the infected cell and are subjected to Nef 
cellular trafficking and conformational status. As a myristoylated protein, Nef is addressed 
to cellular membranes. However, it has been shown that less than 50% of the protein locates 
at this site, and that the majority of Nef is cytossolic (Fackler et al., 1997; Kaminchik et al., 
1994; Niederman et al., 1993; Welker et al., 1998). After membrane targeting, Nef is rapidly 
internalized though interaction of its C-terminal flexible loop and cell proteins involved in 
the endocytic pathways. It has been shown that while Nef is in its membrane-bound form it 
appears more compactly folded, suggesting that membrane-bound and cytossolic Nef 
shown distinct accessible interaction domains (Breuer et al., 2006), which could explain the 
distinct phenotypes of Nef. Nef’s ability to dimerize or even oligomerize can also function as 
a mechanism of regulating Nef’s effects (Breuer et al., 2006; Dennis et al., 2005). 
Exogenous Nef have been shown to enter monocytes/macrophages, B cells and Dendritic 
Cells (DC) by adsorptive endocytosis. Nef also binds to the surface of T cells, but is not 
internalized by this cell type. No specific receptor to this protein has yet been identified 
(Alessandrini et al., 2000). The finding that Nef is found in sera of HIV+ positive subjects in 
a concentration of 10ng/ml show that this protein is somehow secreted and that this event 
should have a role in pathogenesis. It is assumed that this concentration could be even 
higher in lymphnodes or other sites where virus-producing and target cells are tightly 
packaged (Fujii et al., 1996). Until now no mechanism by which Nef is secreted from cells 
have been identified. However, since it is involved in cellular trafficking and the biogenesis 
of the Multi-Vesicular Bodies (MVBs), it is possible that Nef is packaged in some of these 
vesicles that are later exocyted from the cell. Uninfected cells could internalize Nef by 
endocytosis, pinocytosis or other unknown mechanisms. Exogenous Nef recapitulates in 
part the effects described for endogenous produced Nef (Quaranta et al., 2006; Varin et al., 
2003). Still, some divergences appear, as some evidences showing that Nef can have distinct 
effects on an infected or uninfected cell (as the stimulation of apoptotic or non apoptotic 
status). Thus, Nef’s delivering route is also a determining factor of the phenotype 
modulated by Nef. Therefore, Nef fits the Trojan horse hypothesis, which suggests that the 
virus take advantage of the deliberate secretion of highly immunogenic virions proteins, not 
packaged into viral particles, capable of modulating phenotypes on nearby cells, favoring 
HIV infection (Gould et al., 2003). 
Nef activates many cells types to, ultimately, activate CD4+ T cells (and also activates the 
CD4+ T cell itself). The effect of Nef on cellular activation has been described in DCs, B cells, 
and macrophages, all cell types known to activate CD4+ T cells (Mahlknecht et al., 2000; 
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Quaranta et al., 2006; Xu et al., 2009). By activating CD4+ T cells, Nef favours infection 
spread, as well as increases the pool of permissive cells and transcription from the virus 
promoter on cells already infected. 
Nef interacts with a number of serine and tyrosine protein kinases usually by its PxxP 
domain, known to bind proteins with SH3 domains (Saksela et al., 1995). Binding of Nef to 
these proteins lead to their activation, and activation of the pathway in which they are 
included. Some of these kinases include Hck, PAK1, Lyn, c-Raf, and p53, but many more 
have been described (Arold et al., 1998; Baur et al., 1997; Cheng et al., 1999; Greenway et al., 
2002; Hodge et al., 1998; Lu et al., 1996; Saksela et al., 1995).  Nef recruits several molecules 
involved in TCR signaling, as Lck and Vav (Baur et al., 1997; Djordjevic et al., 2004; Fackler 
et al., 1999), to glycolipid-enriched domains, leading the T-cell to a preactivation state 
(Simmons et al., 2001). Furthermore, Nef can activate T cells independently of TCR, 
stimulating calcium-dependent signaling by interaction with inositol triphosfate receptor on 
these cells (Manninen and Saksela, 2002). 
Interestinglly, some effects of Nef on signaling can be seen even in the absence of the PxxP 
domain, as STAT3 phosphorilation. For STAT3 phosphorilation the domains necessary for 
interaction with the endocytic machinery, as the diacid domains EE155 and DD174 and the 
dileucine domain LL164 were needed, showing that interaction with SH3 domain containing 
proteins is not the only event related to manipulation of signaling pathways by Nef 
(Percario et al., 2003). 
Activation of the signaling pathways by Nef leads, for instance, to the induction NFkB 
nuclear translocation by inducing phosphorilation of IKK alpha and beta and their 
subsequent degradation (Mangino et al., 2007; Varin et al., 2003). This activation leads to the 
secretion of pro-inflammatory mediators, as IL-1beta, IL-6 and TNFalpha, and chemokines 
as MIP1alpha and beta. Other pathways activated by Nef include AP-1, c-Jun, and MAPK 
ERK1/2, JNK and p38 (Mangino et al., 2007). This effect can take place in many cell types as 
promonocytic cells, Monocyte-Derived Macrophages (MDMs), and DCs (Olivetta et al., 
2003; Quaranta et al., 2006; Varin et al., 2003). The soluble mediators synthesized as the 
result of the activation of these pathways, as IL-6 and MIP-1alpha, activate JAK, leading to 
dimmerization of STAT1 and 3 (Mangino et al., 2007; Percario et al., 2003). Also, as Nef 
activates IRF3, leading to the synthesis of IFNbeta, it also leads to STAT2 activation 
(Mangino et al., 2007). NFkB activation also contributes to synthesis of viral proteins, since 
NFkB is one of the main regulators of the viral promoter (Nabel and Baltimore, 1987). 
Signaling through NFkB and STAT3 are responsible for regulation of antiapoptotic genes on 
infected cells, preventing their death, prolonging viral production and spread (Quaranta et 
al., 2006). Along with TNF, Nef stimulation of NFkB may act blocking caspase 8 activation 
(Wang et al., 1998). 
It has been described that treatment of cells with exogenous Nef are similar to the treatment 
with TNFalpha, and lead to the same outcomes (Mahlknecht et al., 2000; Varin et al., 2003), 
as NFkB, AP-1 and JNK activation. It is thus believed that Nef might engage interactions 
with some actor of the TNFalpha signaling pathway, but such protein have not yet been 
identified (Varin et al., 2003). 
Nef was found in the germinal centers of infected lymphoid follicules, and its presence has 
been observed in IgD+ B cells, although these cells showed no signs of infection, as they lack 
any other viral protein or RNA. On B cells, Nef inhibits CD40-dependent activation and 
IgG2 and IgA class-switch. Interestingly, Nef can reach these cells by inducing conduit 
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formation on infected nearby macrophages, and trafficking through them in vesicles that are 
delivered to B cells (Xu et al., 2009). 
AIDS is by many authors considered as the outcome of many immunological disorders. The 
solely expression of Nef in SCID human/mouse model recapitulates many of the AIDS 
symptoms (Hanna et al., 1998; Lindemann et al., 1994; Skowronski et al., 1993). Nef 
completely transfigures signaling of DCs, T cells, monocytes/macrophages, B cells and 
probably many others cell types. These attributes make this protein probably the major 
pathogenicity factor of HIV. 
2.4 Downmodulation of TCR/CD3 
HIV-1 infection in humans and SIVmac infection in rhesus macaques induces overall levels 
of immune activation associated with accelerated T cell turnover rates and increased 
susceptibility to apoptotic cell death that culminates in progression to AIDS in the absence 
of an effective anti-HIV therapy.  Moreover, the accessory protein Nef from both HIV and 
SIV has been implicated in immune activation and disease progression as discussed 
previously. HIV-1 Nef has also been reported to directly enhance the responsiveness of T 
cells to activation (Fenard et al., 2005; Fortin et al., 2004; Wang et al., 2000). Nonetheless, 
non-human primates naturally infected with their species-specific SIVs (e.g., sooty 
mangabeys (SMs) and African green monkeys (AGMs)) generally do not show signs of 
progression to SAIDS (Silvestri et al., 2007; VandeWoude and Apetrei, 2006).  The 
mechanism underlying the remarkable difference in the outcome of infection between these 
primate hosts include T cell activation as a strong predictor of progression to AIDS (Giorgi 
et al., 1999; Sousa et al., 2002). 
The signaling cascade which leads to T-cell activation and differentiation depends on the 
immunoreceptor tyrosine activation motifs (ITAMs) of the TCR/CD3 complex localized in cell 
surface for initiation of signaling cascades, thereby resulting in recruitment and activation of 
multiple protein tyrosine kinases, signaling intermediates, and adapter molecules (Guy and 
Vignali, 2009). TCR/CD3 complexes are composed of the clonotypic ǂǃ heterodimer, the CD3 
ǆ and ǆ heterodimers, the Ǉ homodimer and contain a total of 10 ITAMs  (Alcover and 
Alarcon, 2000). TCR/CD3 complexes are relatively stable but are constantly internalized and 
recycled back to the cell surface by the endocytosis and intracellular trafficking pathway of 
membrane receptors. Besides the host TCR/CD3 complexes equilibrium, SIV and HIV-2 Nef 
bypasses the mechanisms that normally mediate the recruitment of TCR/CD3 complexes to 
the endocytic machinery, therefore, SIV and HIV-2 Nef target the CD3-Ǉ subunit and accelerate 
its endocytosis rate (Howe et al., 1998; Swigut et al., 2003). The proposed mechanisms for TCR-
CD3 endocytosis induced by SIVmac and HIV-2 Nef proteins are based on the interaction of 
Nef with the CD3-Ǉ subunit via the AP-2 clathrin adaptor pathway (Bell et al., 1998; Howe et 
al., 1998; Swigut et al., 2003).   
Although HIV-1 Nef fails to downregulate CD3 (Foster and Garcia, 2008) essentially all SIV 
Nefs, except for a small subset, downmodulate TCR/CD3 complexes to suppress T cell 
activation and programmed cell death (Kirchhoff et al., 2008). The exceptions include the 
chimpanzee precursor of HIV-1, SIVcpz, as well as SIVgsn, SIVmus, SIVmon, SIVgor and 
SIVolc. In contrast, the majority of nef alleles, including those of SIVsmm, SIVmac, and HIV-
2 but also those of SIVrcm, SIVdeb, SIVsyk, SIVblu, SIVsun, SIVtan, SIVsab, SIVden, SIVwrc, 
SIVgri, SIVlho, and SIVasc downmodulated TCR/CD3 efficiently (Schindler et al., 2006; 
Schmokel et al., 2011).  
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In a previous report, an association between Nef proteins of all vpu-containing viruses and 
the loss of ability to down-modulate the TCR/CD3 was demonstrated, hence only vpu-
containing viruses were predicted to be unable to down-modulate the TCR/CD3 complexes, 
e.g. HIV-1, SIVcpz, SIVgor, SIVgsn, SIVmus, SIVmon (Schindler et al., 2006). Exceptions to 
this association has been demonstrated since in SIVden strain, in which Nef retains the 
ability to downmodulate TCR/CD3, the vpu gene is present, whereas in SIVolc, which does 
not contain Vpu, Nef protein is unable to perform this function (Schmokel et al., 2011).  
Besides the role of Nef in TCR/CD3 downmodulation a question remains to be understood: 
does CD3 downregulation contribute to the nonpathogenic phenotype of natural SIV 
infections? The reports suggest that a protective role of Nef-mediated TCR/CD3 
downmodulation is needed to reduce the stimulation of virally infected CD4+ helper T cells 
by antigen-presenting cells and might contribute to the nonpathogenic phenotype of natural 
SIV infections. Inefficient CD4+ helper T cell activation would weaken the antiviral immune 
response and might allow the virus to persist at high levels. Indeed, reduced T cell 
activation, proliferation and apoptosis might also allow the host to maintain a functional 
immune system (Kirchhoff et al., 2008). However, two models of experimental SIV infection 
appear to be contradictory to this hypothesis. First, SIVmac, a virus inadvertently 
transmitted from naturally infected SMs to macaques in captivity (Daniel et al., 1985), causes 
immunodeficiency and SAIDS in macaques despite the fact that its Nef protein efficiently 
downmodulates TCR/CD3. Second, SIVmac viruses harboring the HIV-1 nef gene (the so-
called Nef-SHIVs) do not induce greater pathogenicity than wild-type SIVmac in 
experimentally infected macaques (Alexander et al., 1999). Taken together, further analyses 
are required to clarify the biological significance of CD3 downregulation to the 
pathogenicity of SIV, HIV-1, and HIV-2 for their hosts. 
Although compeling evidences that the functions of Nef described above can be related to 
primate lentiviral pathogenesis, each one of them individually can be excluded as the 
mechanism by which this protein increases viral infectivity by a number of other evidences. 
Nef is a multifunctional protein and besides interacting with a multitude of host cellular 
factors and to contribute to virus pathogenesis it seems to play a key role during the primate 
lentiviral replication cycle to make viral particles optimally infectious. The participation of 
Nef during the different steps of the primate lentiviral replication cycle will be reviwed in 
the next sections. 
2.5 Interference with cell cytoskeleton 
It has been demonstrated that HIV-1 takes advantage of the cytoskeleton dynamics in order 
to ensure viral entry and transport within and egress from target cells, as well as to interfere 
with other cellular processes (Fackler and Krausslich, 2006). The specific interference of Nef 
with cell cytoskeleton for virus entry will be discussed on section 4.1.  
Nef’s interference on the actin dynamics is also an important mechanism for Nef-induced 
alterations of T-cell receptor (TCR) signaling (Haller et al., 2006; Rudolph et al., 2009). TCR 
engagement triggers actin rearrangements that control receptor clustering for signal 
initiation and dynamic organization of signaling protein complexes to form an 
immunological synapse. Nef inhibits immunological synapse formation by a dynamic 
process involving rapid actin modifications (Thoulouze et al., 2006). TCR signaling events at 
the immunological synapse, including F-actin remodeling and re-localization of Lck, are 
evolutionary conserved activities of highly divergent lentiviral Nef proteins (Rudolph et al., 
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2009). Indeed, alteration of the endocytic and signaling pathways at the immunological 
synapse likely impacts the function and destiny of HIV-1-infected cells. T-cell chemotaxis 
constitutes an essential function of the immune response, since active secretion of 
chemokines controls homing and recruitment of leukocytes into tissues. A number of 
studies have reported that Nef affects T-cell chemotaxis through the modulation of Rho-
GTPase-regulated signaling pathways (Janardhan et al., 2004; Lee et al., 2008; Swingler et al., 
1999).  
HIV-1 infection of primary human macrophages induces the formation of tunneling 
nanotubes (TNT) by Nef (Lamers et al., 2010). TNT is a novel communication system 
observed in immune cells, including B, T and NK cells, neutrophils and monocytes, as well 
as in neurons and glial cells, which can be utilized by HIV to spread viral particles by an 
intercellular route (Gerdes et al., 2007).  
The effect of Nef is dependent on its myristoylation and SH3 domains. While Nef 
myristoylation is required for its membrane association, the proline-rich SH3-binding domain 
is involved in Nef association with Vav, DOCK2-ELMO1, Rac and the cellular kinase Pak2 
(Roeth and Collins, 2006). First, Vav is activated by the interaction between its C-terminal SH3 
domain and PxxP motif in Nef leading to Vav’s downstream effectors activation, resulting in 
morphological changes, cytoskeleton rearrangements and the activation of the c-Jun N-
terminal kinase (JNK)/stress-activated protein kinase (SAPK) cascade (Fackler et al., 1999). 
Then, Nef activates Rac by binding the DOCK2-ELMO1 complex, a key activator of Rac in 
antigen- and chemokine-initiated signaling pathways, and this interaction is linked to the 
abilities of Nef to inhibit chemotaxis and promote T cell activation (Janardhan et al., 2004). 
Finally, Nef association with Pak2 prevents actin remodeling to impair host cell motility by 
disregulation of cofilin, which is an actin-depolymerizing factor that promotes actin turnover 
and subsequent cell motility (Stolp et al., 2010). 
The cytoskeleton reorganization induced by Nef is associated with an impairment of cell 
movements combined with induction of long filopodium-like structures in T lymphocytes 
(Stolp et al., 2010).  In summary, Nef displays a variety of complex effects on the motility 
and cellular morphology of HIV-1-infectected T lymphocyte, thus resulting in a strategy to 
improve immune evasion and viral spread in the infected host. 
3. SIV Nef to counteract a cellular restriction factor? 
3.1 Tetherin and Nef  
The cellular protein Tetherin (also known as BST-2, CD317, or HM1.24) is a membrane 
protein with a number of distinct characteristics indicating that it plays a straight role in 
suppressing the release of virions from infected cells. Tetherin was discovered in 2008 when 
groups of Bieniasz and Guatelli were investigating the HIV-1 Vpu anti-Tetherin activity 
during the virus life cycle (Neil et al., 2008; Van Damme et al., 2008). The N-terminal of this 
protein is localized in the cytoplasm, followed by a transmembrane domain and a coiled-coil 
extracellular domain. The extracellular domain contains two N-linked glycosylation sites 
that are modified by a glycosyl phosphatidyl inositol (GPI) membrane anchor at the C-
terminus (Kupzig et al., 2003; Rollason et al., 2007). 
Tetherin functions as a broadly acting antiviral factor because besides lentiviruses, Tetherin 
restricts the release of different retroviruses, including alpha-, beta-, delta-, spumaviruses, and 
other viruses as arena- (Lassa), filo- (Marbuburg, Ebola), and herpesviruses (KSHV) (Mansouri 
et al., 2009). Tetherin belongs to the three main classes of restriction factors in addition to 
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APOBEC3G, which induces hypermutation in the retroviral genome, and the Tripartide Motif 
Protein 5ǂ (TRIM 5ǂ), which acts as new incoming retroviral capsid restriction factor (Neil et 
al., 2008). HIV-1 overcomes these restrictions factors by the action of accessory proteins as Vif 
and Vpu that act against cellular substrates APOBEC3G and Tetherin, respectively, to ensure 
viral persistence, replication, dissemination, and transmission (Malim and Emerman, 2008).  
Tetherin is antagonized by the HIV-1 protein Vpu (Neil et al., 2008; Van Damme et al., 2008).  
Vpu interact directly with the transmembrane domain of Tetherin with a high specificity 
(Gupta et al., 2009; McNatt et al., 2009). The mechanism by which Vpu remove Tetherin 
from the cell surface was proposed as Vpu recruits ǃ-TrCP, a substrate adaptor for an SCF 
E3 ubiquitin ligase complex, to remove Tetherin via post-endocytic membrane trafficking 
events (Douglas et al., 2009; Mitchell et al., 2009). As a consequence, Vpu leads to 
moderately reduced levels of Tetherin at the host cell surface and a modest decrease in total 
cellular Tetherin (Douglas et al., 2009; Mitchell et al., 2009; Van Damme et al., 2008).  
Anti-Tetherin factors are also found in other viruses. Kaposi's sarcoma-associated 
herpesvirus (KSHV) uses K5/MIR2 protein to ubiquitinate and target Tetherin for 
degradation (Mansouri et al., 2009). Ebola virus glycoprotein antagonizes Tetherin-mediated 
restriction (Kaletsky et al., 2009; Lopez et al., 2010). Vpu functions as an anti-Tetherin factor 
in lentiviruses as SIV from  Skye’s monkeys (Lopez et al., 2010). Since lentiviruses of the 
SIVsmm/mac/HIV-2 lineage do not have a vpu gene to impair Tetherin aactivity, this role 
was taken by other viral proteins. Some primate lentiviruses (e.g., SIVsmm, SIVmac, and 
SIVagm) use the Nef protein to antagonize Tetherin (Jia et al., 2009). SIVcpz from 
chimpanzees and SIVgor from gorillas, which contain the vpu gene and are the ancestors of 
HIV-1, also use Nef to antagonize Tetherin (Yang et al., 2010). HIV-2 on the other hand, uses 
its envelope glycoprotein Env (and not Nef) to downmodulate Tetherin (Bour et al., 1996; Le 
Tortorec and Neil, 2009; Ritter et al., 1996). SIVtan from Tantalus monkeys uses both Env 
and Nef to antagonize Tetherin (Gupta et al., 2009; Zhang et al., 2009). 
Analyses of the interactions between Tetherins from different primate species and the 
antagonist proteins used by viruses that infect those hosts have revealed a high degree of 
species-specificity. For example, the HIV-1 Vpu protein antagonizes human but not monkey 
Tetherin (Gupta et al., 2009; McNatt et al., 2009). These antiviral factors have sequence 
divergences that may constitute barriers to zoonotic viral transmission from animal 
reservoirs. For instance, the specificity of SIV Nef for rhesus Tetherin mapped to a four 
amino acid sequence in the cytoplasmatic domain that is missing from the human protein, 
whereas the specificity of HIV-1 Vpu for human Tetherin mapped to amino acid differences 
in the transmembrane domain (Jia et al., 2009).  
Tetherin is usually only expressed efficiently in plasmacytoid dendritic cells, some cancer 
cells, terminally differentiated B cells, and bone marrow stromal cells (Blasius et al., 2006; 
Goto et al., 1994; Ishikawa et al., 1995) and its expression is strongly induced by type I 
Interferons (Neil et al., 2007). Tetherin is constitutively expressed on the surface of HeLa, 
Hep-2 and Jurkat cells lines but is not detected in other cell lines, such as 293T, HOS and 
Cos-7 cells (Van Damme et al., 2008). The absence of Tetherin expression in some cell lines 
suggest that the anti-Tetherin function of Vpu or Nef may not be obligatory for efficient 
viral replication in vitro and disease progression in vivo. It also remains to be determined 
whether Tetherin will promote or block cell-to-cell transmission (Gummuluru et al., 2000; 
Neil et al., 2006; Neil et al., 2008; Vendrame et al., 2009). Thus, further studies on the effect of 
Tetherin for primate lentiviral replication are necessary. 
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4. Nef and the basic steps of the HIV and SIV replication cycle 
4.1 Nef and virus entry and uncoating 
HIV and SIV enter target cells by fusion of the viral envelope with the cell membrane 
followed by the delivery of the virion core inside the cell cytoplasm. The host cell 
cytoskeleton imposes the first physical barrier to viral invasion upon entry and Retroviruses 
have evolved mechanisms to interfere with cytoskeleton arrangement. More specifically, it 
has been proposed that Nef could reorganize actin to ensure initial viral core movement. 
Association of Nef with viral cores (Kotov et al., 1999) and cellular proteins involved in actin 
cytoskeleton dynamics such as Vav and PAK (a member of the p21-activated kinase family) 
could account to the early movement of the viral cores through cortical actin and into 
microtubules (Roeth and Collins, 2006).  Therefore, it has been proposed that this function of 
Nef could account to the increase in virus infectivity (Campbell et al., 2004).  
Lentiviruses infect non-dividing cells implying that the recently formed viral DNA enters 
the nucleus through the nuclear pore. In fact, the so-called Pre-Integration Complex (PIC), 
formed by the double strand viral DNA associated with the viral Integrase (IN) and other 
viral and cellular proteins gains access to the nucleus by being actively transported through 
the nuclear pore. This phenomena imposes the necessity of an uncoating step because the 
diameter of the viral core (60 nm wide) exceeds that of the nuclear pore (30 nm) (Arhel, 
2010). Uncoating is the process of core disassembly that takes place after virus entry into the 
host cell. Three distinct models of lentivirus uncoating have been proposed: i) in the first 
model it is predicted that disassembly occurs spontaneously and immediately after the viral 
core has entered the cell cytoplasm; ii) in the second model disassembly occurs in a time 
frame when the reverse transcription of the viral RNA has already started; iii) in the third 
model core disassembly occurs later on when the synthesis of the viral DNA is already 
completed and the Reverse Transcription Complex (RTC) is in close proximity of the nuclear 
membrane. Recent evidences favor the third model.  
Disassembly of the viral cores has to occur in an optimal rate to ensure that reverse 
transcription is successfully completed. This was evident from studies demonstrating that 
mutations in Gag affecting core stability reduced reverse transcription in cells (Brun et al., 
2008; Forshey et al., 2002). Since Nef-deleted viruses have a defect in reverse transcription 
unrelated to a direct role of Nef in the Reverse Transcriptase (RT) activity (which will be 
discussed in section 4.2), it was proposed that the absence of Nef in the incoming viruses 
would affect core stability, compromising uncoating and therefore reverse transcription. 
However, studies failed to show this effect of Nef ruling out a role for Nef during viral 
uncoating (Cavrois et al., 2004; Forshey and Aiken, 2003). 
Interestingly, the route of viral entry seems to dictate the Nef requirement for optimal 
infectivity. Whereas wild type HIV-1 or amphotropic murine leukemia glycoprotein-
pseudotyped HIV-1 virions that promote membrane fusion and cell entry through the 
plasma membrane are dependent on Nef to be fully infectious, HIV-1 virions pseudotyped 
with the glycoproteins for which fusion and entry take place after endocytosis and upon 
endosome acidification (e.g. Vesicular Stomatitis Virus glycoprotein - VSV-G) do not require 
Nef to increase infectivity (Aiken, 1997; Chazal et al., 2001; Luo et al., 1998).  As pointed out 
previously, the treatment of target cells with drugs that disrupt the cortical actin 
cytoskeleton complements the infectivity defect of Nef-deleted virus (Campbell et al., 2004). 
Therefore, taken together, and discarding the role of Nef in facilitating viral uncoating 
(Cavrois et al., 2004; Forshey and Aiken, 2003), these findings have been interpreted as 
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evidence for a role of Nef in facilitating the penetration of the viral cores through the cortical 
acting barrier, a function that would become dispensable if entry occurs through 
endocytosis. However, it was recently demonstrated that the presence of Nef itself in viral 
particles by means of its incorporation through Vpr (Nef.Vpr fusion protein) was not 
sufficient to increase viral infectivity (Laguette et al., 2009). Moreover, it has been shown 
that in some cases the requirement for Nef to achieve optimal viral infectivity is not 
circumvent by directing viral entry through endocytocis followed by exposure to low pH. In 
an elegant study it was shown that pseudotyping HIV-1 cores with the Rous Sarcoma Virus 
A (RSV-A) receptor, the Tva molecule, and using this pseudotypes to infect cells harboring 
the RSV-A glycoprotein Nef was still necessary for optimal infectivity (Pizzato et al., 2008). 
Therefore it remains to be fully established that the importance of Nef to the increase of viral 
infectivity is solely related to its effect on the actin rearrangement upon viral entry and 
whether other components of the viral core also contribute in the process.  
4.2 Nef and reverse transcription 
Upon entry to the target cell the reverse transcription step of the Retroviral replication cycle 
is initiated. Reverse transcription is defined as the synthesis of the viral double strand DNA 
(dsDNA) from the viral single strand RNA genome (ssRNA), which is catalyzed by the two 
sub unities of the viral Reverse Transcriptase (RT), p66 (polymerase and RNase H) and p51 
(polymerase). A pre-requisite to reverse transcription is the formation of a pre-initiation 
RTC during viral maturation within the producer cell. Minimally, the pre-initiation RTC is 
composed by two copies of the viral ssRNA genome, the tRNA primer and the viral 
enzymes RT and IN. Other viral proteins including nucleocapsid (NC) and the accessory 
proteins Vpr and Nef are also part of the pre-initiation RTC (Warrilow et al., 2009). An 
important characteristic of the pre-initiation RTC for most of the retroviruses is that, in 
virions, it undergoes minimal reverse transcription and this event is trigged in the target cell 
by factors that are still not completely understood. One of the major events triggering 
reverse transcription seems to be the exposure of the RTC to the non-limiting concentration 
of deoxyribonucleotides within the target cells. Once the reverse transcription is initiated 
structural changes occur releasing most of the protein content of the pre-initiation RTC, 
turning it into a mature RTC.  For instance, most of the RT and the Nef content is shed at 
this time. It is being now recognized that cellular proteins such as helicases and other 
cellular factors are also present at the RTC and must play important roles during reverse 
transcription (Warrilow et al., 2010). The RTC migrates towards the nuclear pore through 
association with the cell cytoskeleton and once reverse transcription is completed the RTC is 
fully maturated in the PIC to enter the nucleus for the next step of viral dsDNA integration 
(Warrilow et al., 2009). One of the models of uncoating discussed previously predicts that 
only at the stage of fully maturation of the RTC into PIC is that most of the CA protein 
content is shed. Therefore, uncoating occurs later after reverse transcription and implies that 
an optimal core microenvironment is maintained in order to avoid dilution of the crucial 
RTC contents and the attack of deleterious cellular factors (Arhel, 2010).  
Reverse transcription occur in two distinct phases; the early phase encompasses the 
formation of the negative strand DNA (cDNA) from the genomic RNA, while in the late 
phase the positive strand DNA is synthesized from the cDNA generating the dsDNA. RT is 
the sole enzyme that catalyses the DNA synthesis and the degradation of the viral RNA 
template. However, IN has a crucial role during the initiation of the reverse transcription by 
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physically interacting and increasing the processivity of the RT (Dobard et al., 2007; Wu et 
al., 1999). Therefore, not only the high stoichiometry of the RT must be maintained during 
reverse transcription but also that of the IN. Other viral proteins have been implicated in 
facilitating or participating in reverse transcription. For instance, NC and Vpr physically 
interact with RT as well as with IN and may play an important role during the initiation of 
reverse transcription (Warrilow et al., 2009).  
The presence of Nef in the RTC is well documented (Forshey and Aiken, 2003; Kotov et al., 
1999), as well as its function in stimulating the synthesis of the viral dsDNA during reverse 
transcription in the target cell (Aiken and Trono, 1995; Schwartz et al., 1995). However, Nef 
does not influence RT activity per se since the in vitro activity of RT from Nef-deleted viruses 
is not altered and the treatment of these viruses with deoxyribonucleotides previous to 
infection of the target cells restores viral infectivity (Aiken and Trono, 1995; Khan et al., 
2001).  These observations prompt to the conclusion that Nef would function in an early step 
during the viral replication cycle before reverse transcription. Studies have failed to 
demonstrate any influence of Nef in virus entry, delivery of the viral cores to the cell 
cytoplasm or core disassembly (Cavrois et al., 2004; Forshey and Aiken, 2003; Miller et al., 
1995). Other study had shown however that this early effect of Nef can be attributed to a 
post-entry event like facilitating the movement of the viral core through cortical actin 
located beneath the plasma membrane (Campbell et al., 2004), however this has recently 
being disputed since two different studies demonstrated that the effect of Nef in increasing 
viral infectivity derives not from its presence in the viral particles but from some effect on 
the virus producer cell (Laguette et al., 2009; Pizzato et al., 2008).  
4.3 Nef and virus assembly 
The viral genomic RNA is transported to the cytoplasm were it leads to the synthesis of the 
Gag and GagPol polyprotein precursors. These precursors oligomerize and traffic to the 
plasma membrane by still not completely understood pathway(s). Concomitantly, the Env 
glycoproteins are translated in the ER and are transported to the plasma membrane via the 
secretory pathway. Membrane-targeted Gag and GagPol polyproteins recruit the viral 
genomic RNAs and assemble at the plasma membrane, leading to the induction of 
membrane curvature at the site of assembly, while the Env glycoproteins are incorporated 
into the budding particles during the assembly process. Experimental evidences suggest an 
important role for lipids and especialized cell membrane microdomains for the optimal 
assembly of HIV-1. 
Also, HIV and SIV and many other viruses infect their target cells by interacting with the 
surface membrane microdomains enriched with cholesterol, sphingolipids and other 
saturated lipids, as well as specific types of proteins, referred as lipid rafts or detergent-
resistance membranes (DRMs) (Nayak and Hui, 2004). Lipid rafts form a liquid-ordered 
state through lipid-lipid interactions and are central for attachment of proteins when 
membranes are moved around inside the cell and during signaling transduction (Verkade 
and Simons, 1997). Glycosylphosphatidylinositol (GPI)-anchored proteins, transmembrane 
proteins and doubly acylated tyrosine kinases of the Src family all associate and are 
incorporated into DRMs. 
Moreover, Nef has been proposed to have a role during the assembly step of the viral 
replication cycle. Several studies reported that HIV-1 Nef expression alters the lipid 
composition of virions by increasing cholesterol biosynthesis and its incorporation into 
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DRMs, therefore Nef increases the concentration of Gag and colocalizes with viral structural 
components in the DRMs. These features were linked to the increase in viral infectivity and 
the facilitation of virus spread (Wang JK, 2000; Zheng et al., 2003). Also, it seems that 
infectivity enhancement by Nef requires its association with components of the assembling 
HIV/SIV particles. Gag from HIV/SIV associates with DRMs and disruption of Gag-raft 
interactions impairs virus particle production (Chukkapalli et al., 2010). It has been 
demonstrated that fusion of the host protein cyclophilin A (CypA) to Nef allowed controlled 
incorporation of Nef into HIV-1 particles via association with Gag during viral particle 
assembly for enhancement of HIV-1 infectivity (Qi and Aiken, 2008). 
Besides the effect of Nef association with DRMs to viral infectivity, Nef also associates with 
these membrane microdomains together with several proteins involved in the initiation and 
propagation of T cell signaling and could therefore affect the later steps of the replication 
cycle.  Nef was shown to interact with Pak-2 in lipid rafts (Krautkramer et al., 2004), which 
may result in increased frequency of cells expressing transcriptionally active forms of NF-κB 
and NFAT and increased T cell activation (Fenard et al., 2005).  The interaction of Nef with 
PAK2 is conserved for many Nef proteins derived from HIV-1, HIV-2, and SIV strains 
(Sawai et al., 1995), and was demonstrated to be mediated by Cdc42 and Rac, which are 
PAK 2 activators, and being dependent on raft integrity (Krautkramer et al., 2004).  While 
delivers activation stimulus to CD4 T cells Nef also mediates exclusion of molecules such as 
Lck, Vav, and TCRǇ E2 known as ubiquitin-conjugating enzyme (UbcH7) from rafts in lipid 
rafts to avoid the negative regulation of T cell signaling (Simmons et al., 2005). 
Rafts were also initially proposed to act as platforms for virus entry, facilitating interactions 
between CD4 receptors and the incoming virions (Chukkapalli et al., 2010). This role has 
been, however, questioned, because CD4 molecules unable to associate with rafts still allow 
virus entry (Percherancier et al., 2003; Popik and Alce, 2004).  Moreover, Sol-Foulon and co-
workers proposed that the effects of Nef on CD4 downregulation and the increase in viral 
infectivity were independent of lipid rafts (Sol-Foulon et al., 2004). Discrepancies in 
methodological approaches from these authors with the reports described before could 
account for the observed differences on this effect of Nef. Therefore, more detailed studies 
are needed in order to establish a connection between the localization and the effects of Nef 
in DRMs and its importance for virus replication and infectivity.  
Endocytosis may be classified into two categories, clathrin dependent and independent. The 
role of Nef in inducing clathrin-dependent endocytosis of some surface receptors, as CD4 
(Aiken et al., 1994; Chaudhuri et al., 2007; Garcia and Miller, 1991; Mariani and Skowronski, 
1993), triggering the de novo formation of clathrin coated pits and acting as a connector 
between receptor cargo and the endocytic machinery (Foti et al., 1997) has been addressed 
here. Dyn2 was identified as a Nef binding partner through immunopreciptation assays, 
and is intrinsically related to clathrin-dependent endocytosis (Pizzato et al., 2007). It is a 
ubiquitously expressed member of large GTPases that is thought to aid the fission step that 
separates clathrin-coated vesicles from the plasma membrane (Hinshaw, 2000). Nef 
distinguishes between the three isoforms of Dyn, binding specifically to Dyn2, and this 
interaction is conserved among different nef alleles. The interaction is dependent of the 
Middle and GTPase Effector domains of Dyn2 and surface-exposed core domain residues in 
Nef, as L112, F121 and D123. Loss of Dyn2 interaction leads to loss of infectivity, however, 
Nef mutants that are able to bind Dyn2, as LL164,165AA, also show infectivity impairment, 
showing that Dyn2 interaction is not sufficient for Nef induced infectivity enhancement 
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(Pizzato et al., 2007). Interestingly, this was the same domain considered crucial for sorting 
of Nef on clathrin coated vesicles, showing that Nef may have multiple mechanisms in order 
to gain access to clathrin-dependent endocytosis (Greenberg et al., 1998a).  
Furthermore, the increase in viral infectivity by Nef through binding to Dyn2 is dependent 
on clathrin and the proposed mechanism predicts that by binding to Dyn2 Nef would gain 
access and selectively modify specific membrane domains in the infected cell from which 
viral assembly occurs (Pizzato et al., 2007). On the other hand, clathrin by its turn may also 
have another direct role during HIV infection. At least for HIV-2 and SIVmac, the p6 peptide 
within Gag is thought to directly engage clathrin, by a motif that resembles the classic 
clathrin box, LLpL(-), where p is a polar residue and (-) a negatively charged one 
(Kirchhausen, 2000; Popov et al., 2011). It was also shown that although HIV-1 lacks such 
sequence in Gag or GagPol, it may also engage clathrin through GagPol, in a mechanism 
dependent of the IN region of this polyprotein (Popov et al., 2011). This might be explained 
by the enhanced GagPol dimerization rate that a GagPol precursor deleted in the IN domain 
possess, which could occlude a putative clathrin interaction surface (Bukovsky and 
Gottlinger, 1996). Since Nef interacts with GagPol and PR, it may also decrease GagPol 
dimerization, resulting in a better-exposed clathrin interacting surface (Costa et al., 2004; 
Miller et al., 1997; Pandori et al., 1998).  
4.4 Nef and virus budding  
The endo-lysosomal sorting machinery was first described in yeasts, but is well conserved in 
mammals. In yeasts it is called VPS pathway (for Vacuolar protein sorting), and the proteins 
of this pathway are denominated class E proteins, as their inactivation leads to the 
formation of an enlarged and abnormal membrane compartment. Class E proteins can 
present themselves as isolated proteins or as hetero-oligomeric complexes of high molecular 
weight known as ESCRT (Endosomal Sorting Complex Requires for Transport) (von 
Schwedler et al., 2003). 
In mammals, this machinery is involved in the sorting of proteins to many cellular 
compartments, as endosomes, lysosomes, Golgi complex and endoplasmatic reticullum. The 
pathway initiates with the ESCRT-I recruitment to the already ubiquitinated (ESCRT 
tagging) cytoplasmatic portion of the protein to be sorted. This first recruitment is made by 
the cellular proteins STAM and HRS (referred by some authors as ESCRT-0). From this 
point, two pathways might be taken: ESCRT-I activates a second complex named ESCRT-II, 
or it recruits Alix/AIP-1, a central protein of the ESCRT pathway, but that is not a stable 
part of any of the three complexes. In both cases, the ESCRT-III is recruited, whose factors 
bind directly to intracellular membranes and promote its invagination, usually to an 
endosome. Due to its morphology, endosomal compartments that contain vesicles in its 
interior are called Multivesicular Bodies (MVBs). This structure might have two fates, 
lysosomes fusion, delivering its content to degradation, or fusion with the plasmatic 
membrane, liberating its vesicles as exosomes (Strack et al., 2003). 
The topology of viral budding is analogous to the MVBs formation, and to the membrane 
fission event that happens on mitosis. Therefore it is reasonable that the same cytoplasmatic 
machinery used for the MVBs biogenesis is co-opted by viral specific motifs in viral proteins 
named late domains in order to perform viral budding (Fujii et al., 2007). 
Three types of late domains have been characterized in a variety of viral proteins: P(T/S)AP, 
responsible for the interaction with the ESCRT-I component, Tsg101; PPxY, that engage 
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interactions with the Nedd4 ubiquitin ligase family; and YPxL, that interact with Alix/AIP-1 
(Freed and Mouland, 2006). The fact that these late domains maintain its functionality even 
when translocated to other regions of viral proteins or swapped between distinct viruses 
suggest that they serve as anchoring sites to cellular factors, rather than structural elements 
(Garrus et al., 2001). 
On HIV-1 and SIV, the budding process initiates concomitantly with the end of the viral 
particle assembly, which is orchestrated by the different Gag domains. The PTAP motif 
contained in p6 peptide within Gag is considered the main late domain of HIV. However, 
the HIV genome holds two more late domains, the YPxL also located in p6 and the YPLT 
domain in Nef, both capable of interacting with Alix/AIP-1. Nef physical and direct 
interaction with Alix/AIP-1 has been demonstrated both in vivo and in vitro (Costa et al., 
2006). Nef can substitute for the L domain of a p6-deleted Gag polyprotein when fused to its 
C-terminal, restoring viral budding. Also, a Vpr.Nef chimera was able to restore viral 
budding when the PTAP domain in p6 was disrupted (Costa et al., 2006). 
In CEM and SupT1 cell lines, Nef was shown to increase biogenesis of MVBs, a feature that 
can be useful for budding (Costa et al., 2006; Stumptner-Cuvelette et al., 2001). HIV budding 
toward MVB was seen in many cell lines, and can be especially decisive in macrophages, a 
lineage known to have well-developed endosomal machinery. Accumulation of late 
endosomes was dependent of the YPLT domain in Nef, and requires Nef interaction with 
Alix/AIP-1. 
4.5 Nef and virus maturation 
The retrovirus enzymatic and structural proteins are produced by the translation of a 
polycistronic RNA and originate the polyprotein precursors Gag and GagPol (Frankel and 
Young, 1998). The viral PR (Navia et al., 1989) catalyses the hydrolysis of the peptide bonds 
of the polyproteins’ cleavage sites originating the mature proteins capable of generating an 
infectious particle (Louis et al., 2000). 
The lentiviral PR is composed of 99 amino acids, and is synthesized as part of the GagPol 
precursor polyprotein. As it contains an aspartic acid in the center of the catalytic domain, 
the HIV and SIV PR are classified as members of the aspartyl PR family (Navia et al., 1989). 
Some features separate cellular aspartyl PRs from primate lentiviral PR. Unlike cellular 
aspartyl PRs, which are monomeric, viral aspartyl PRs are dimeric and must dimerize in 
order to gain catalytic activity. Therefore, the first step of PR activation is the dimerization of 
two GagPol molecules (Pettit et al., 2005; Weber, 1990). Other feature is that the cleavage 
sites recognized by HIV and SIV PR do not share amino acid identity on the cleavage 
sequence, or on its flanking regions (Hellen et al., 1989; Krausslich et al., 1988). Finally, the 
last characteristic that separate HIV and SIV PR from its cellular relatives is that, as for 
cellular PRs the whole catalytic machinery is pre-formed, and its activation lies mostly on 
the cleavage of a zymogen (Tang and Wong, 1987), for HIV and SIV PR the activation is 
extremely controlled by mechanisms involving protein folding, zymogen cleavage, PR 
context, interactions and pH (Gatlin et al., 1998; Partin et al., 1991; Pettit et al., 2004). These 
abundant regulatory mechanisms point out that the correct PR activation is essential for the 
formation of infectious particles, and that a premature activation must be avoided. Such 
activation could lead to complete viral processing before the completion of budding, 
resulting in the diffusion of viral constituents on the cytosol and altering the protein ratio in 
the budding particle (Pettit et al., 2004). 
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After dimerization, the first cleavages events occur in cis. The first cleavage site is located 
between sp1 and NC, and the second is inside the p6* region of the GagPol precursor 
polyprotein, divinding p6* in an octapeptide (sometimes referred as Transframe Peptide, 
TFP) and a 48 amino acids region that is immediately upstream the PR. These two cleavages 
generate the processing intermediates MA-CA-sp1 (42KDa), NC-TFP (7,4KDa) from Gag 
and p6*-PR-RT-IN (113KDa) from Pol (Pettit et al., 2004). It is thought that at this point p6* 
acts as a zymogen, lying on the catalityc center and blocking further cleavages (Partin et al., 
1991). In order to continue processing an event capable of dislodging p6* from the catalic 
site is needed. Many events have been alleged as capable of so. The pH decay that occurs 
during the budding is the fit theory. However, it is not excluded that some cellular or viral 
protein may participate in this process.  For instance, it has been demonstrated that the viral 
accessory protein Nef binds specifically to the p6* region of the GagPol precursor (Costa et 
al., 2004; Jesus da Costa et al., 2009).   
It is well established that the Nef protein from both HIV-1 (Chen et al., 1998; Freund et al., 
1994; Miller et al., 1997; Pandori et al., 1998) and -2 (Schorr et al., 1996)  is cleaved by the 
viral PR. Initially, the cleavage site within Nef was demonstrated to localize to the N-
terminal region generating a 9kDa membrane anchor domain and a 20kDa Nef core domain 
(30kDa core domain in the case of HIV-2).  These cleavage forms of Nef are recognized only 
inside the viral particles, implying that cleavage takes place during the viral maturation step 
that culminates with the formation of mature infectious viruses. Although the HIV-2 PR 
cleaves Nef from HIV-1 (Schorr et al., 1996), there is no amino acid sequence conservation of 
the cleavage sites between Nef from HIV-1 and HIV-2. While in the HIV-1 Nef the well 
established cleavage site localizes between the Tryptophan 57 and Leucine 58, in the amino 
acid sequence context 54DCAW*LEAQ61, in HIV-2 Nef the cleavage site is localized 
between the Tyrosine 39 and Serine 40 in the amino acid sequence context 
36GGEY*SQFQ43. Another cleavage site within HIV-1 Nef must exist since two 
independent groups reported a C-terminal cleavage form of Nef with an apparent molecular 
weight of 13kDa (Laguette et al., 2009; Miller et al., 1997). Recent data from our group 
demonstrated that the SIVcpz PR also cleaves Nef from SIVcpz during the virus replication 
cycle probably at the same residues as in HIV-1 Nef. Moreover, we have also observed that 
the SIVcpz PR has the capacity of cleaving Nef from HIV-1 generating a Nef core domain 
with the same apparent molecular weight when cleaved by the HIV-1 PR (Sampaio, 
manuscript in preparation). Since there is a great degree of conservation between the nef 
genes from HIV-2 and SIVmac it is likely that the Nef protein from SIVmac is also cleaved 
by the viral PR. 
The fact that Nef is cleaved by the viral PR implicates that these proteins interact during 
the viral replication cycle, however the consequences of this cleavage for viral infectivity 
is still a matter of controversy. Mutations introduced at the main cleavage site on Nef, 
which prevent PR cleavage, does not necessarily correlates with a loss of infectivity. For 
instance, in one study the deletion of the cleavage site of Nef (DCAWL 54-58) prevented 
its cleavage and reduced viral infectivity by 80% (Miller et al., 1997), while in another 
study a similar deletion, which again prevented Nef cleavage, reduced viral infectivity by 
only 20% (Pandori et al., 1998) (Table 1). On the other hand, mutations at the same 
cleavage site that did not disrupt cleavage, like W57A, had a great impact on viral 
infectivity (Chen et al., 1998; Miller et al., 1997). A summary of mutations and deletions 
introduced at the cleavage site of Nef and its impact on viral infectivity are listed on Table 
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1. From this data we can observe that most of the mutations that prevented cleavage 
correlated with a reduction in viral infectivity, however some mutations that still allow 
cleavage to happen also had an impact on viral infectivity. Based on these observations 
authors excluded that processing of Nef by the viral PR could be related to the capacity of 
the former to increase viral infectivity.  
Nevertheless, one can draw some conclusions from these data. First, some of the mutations 
considered not disrupting cleavage of Nef did in fact altered the normal rate of cleavage, as 
for mutations W57A and WL57AA there was much less cleavage observed (Chen et al., 1998; 
Miller et al., 1997), while for mutation CAW55LLL it could be observed a higher cleavage 
rate of the Nef protein (Miller et al., 1997). Therefore, alteration of the cleavage rate could 
interfere with the properties of Nef to increase viral infectivity without disrupting cleavage 
entirely. Second, a complicating issue is that the cleavage site of Nef is also involved with 
downmodulation of CD4 therefore, disruption of this domain could have consequences for 
viral infectivity that could be related to this well established function of Nef. But it must be 
pointed out that the viral infectivity data described here was obtained from CD4 negative 
cells ruling out the effect that these mutations would have on CD4 downmodulation. Lastly, 
as pointed out previously 55CAWL58 is the main viral PR cleavage site but other sites exist 
within Nef (Laguette et al., 2009; Miller et al., 1997). This could explain that however 
impairing the cleavage at the major site viral infectivity increase by Nef would not be 
greatly affected. 
It is not the presence of Nef in the viral particles per se that increases viral infectivity. This 
was proven by a study by Laguette and co-workers (Laguette et al., 2009) where it was 
demonstrated that increasing the amounts of Nef being incorporated within HIV-1 particles 
by means of a Nef-Vpr fusion protein was not sufficient to make viral particles more 
infectious. In any case, this Nef-Vpr fusion was normally processed by the viral PR and 
retained classical Nef functions such as downmodulation of CD4 from the surface of virus 
producer cells. This data therefore indicates that the role of Nef related to the increase in 
viral infectivity occurs during the late stages of the replication cycle in the virus producer 
cells, probably by optimally regulating/modifying the structural and/or enzymatic viral 
components. Some aspects related to this possible function of Nef will be discussed further. 
Interestingly, besides connecting viral PR since being recognized as a specific substrate, Nef 
can also connect the structural/enzymatic polyprotein precursor GagPol through different 
domains either in Nef and in GagPol (Costa et al., 2004; Jesus da Costa et al., 2009). These 
studies demonstrated that the Nef protein from both HIV-1 (Costa et al., 2004)  and SIVmac 
(Jesus da Costa et al., 2009) can interact with the GagPol precursor through the flexible-loop 
domain in Nef and the p6* regulatory region of GagPol. Although the specific amino acid 
residues involved in this interaction in both Nef and p6* were not yet demonstrated, its 
specificity and the biological relevance were. Interaction of GagPol and Nef occurs in cells 
during the HIV-1 replication cycle and was sufficient to explain the dominant negative 
phenotype of an laboratory adapted allele of HIV-1 nef  (Nef F12) which localizes to the ER 
and inhibits the release of Gag and its processing by the viral PR (Fackler et al., 2001; 
Olivetta et al., 2000). The F12 phenotype was recapitulated by a Nef with an ER retention 
signal, meaning that by interacting with GagPol Nef retained this polyprotein precursor 
inside the producer cell avoiding both release and maturation of viral particles (Costa et al., 
2004). Furthermore, the relevance of this interaction was confirmed by an experiment 
demonstrating that release of a late-domain defective HIV-1 from producer cells was 
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rescued by a Nef-Tsg101 fusion protein, indicating that, besides interacting early during the 
expression of GagPol, Nef and the viral structural/enzymatic precursors are present 
concomitantly at the sites of virus budding. While investigating what influence the binding 
of Nef and GagPol would have for HIV-1 infectivity we have also established that Nef from 
HIV binds the cellular Alix protein and correlated these findings with optimal viral 
replication in cells (Costa et al., 2006).  We demonstrated that this interaction correlated with 
the property of Nef to stimulate the synthesis of MVBs in cells and the optimal infection of 
MDMs. Taken together, the fact that Nef binds both the viral precursor GagPol and to the 
cellular Alix protein, which is involved in virus budding, suggest that Nef actively 
participates in a late step of viral replication. We further extended these observations to 
SIVmac, demonstrating that the binding of Nef to both GagPol and Alix is conserved in Nef 
from this virus (Jesus da Costa et al., 2009). The functional relevance of these bindings was 
clearly demonstrated in rhesus macaques. First, informative mutations were introduced into 
the nef gene of infectious SIVmac and this mutant virus used to infect four rhesus macaques. 
Whereas rhesus macaques infected with the WT virus developed high viral loads and 
progressed rapidly to SAIDS, only two of four monkeys inoculated with the mutant virus 
displayed a similar picture, albeit with much delayed kinetics. Importantly, in both cases, 
we observed reversions in SIVNef that restored its binding to SIVGagPol and Alix. In two 
other rhesus macaques, mutant Nef sequences persisted and they developed neither high 
viral loads nor SAIDS.  Further studies in cells provided additional support for these 
findings. Taken together these studies suggest that interactions between Nef, GagPol and 
Alix are important for optimal viral replication and progression to disease in the monkey 
model of AIDS and possibly also pertinent to the human disease since these interactions are 
preserved in both HIV-1 and SIVmac. 
Still, what would be the mechanism by which interacting with GagPol and Alix, Nef 
would stimulate viral infectivity? Recent work from our group demonstrated that Nef that 
from SIVcpz also binds to GagPol from both SIVcpz and HIV-1. Furthermore, our results 
showed that Nef exerts a direct influence upon the viral PR activity:  i) first by 
characterizing a SIVcpz provirus that expresses a N-terminal truncated peptide of Nef 
that is a potent inhibitor of viral processing and consequently viral infectivity and exerts a 
dominant negative activity both against PR from SIVcpz and HIV-1 (Sampaio et al. – 
manuscript in preparation); second by demonstrating that in the absence of Nef 
expression during the replication cycle of HIV-1 the processing kinetics of the Gag and 
GagPol precursors are accelerated, resulting in slightly lower concentration of the 
structural (p24-Capsid protein) and 2-fold lower concentration of the  enzymatic (IN) 
components within viral particles (Mendonça et al. – manuscript in preparation). 
Moreover, the accelerated activity of the viral PR in the absence of Nef expression in the 
producer cells was also demonstrated by the fact that higher concentrations of PR 
inhibitors (e.g. Lopinavir) are required to inhibit virus replication at the same levels as of 
the wild type viruses. Based on this preliminary results a working model was drawn 
(Figure 2), in which the role of Nef for virus infectivity is explained by the following: 
upon binding of the p6* and PR regions, within the GagPol precursor, Nef would function 
as a fine regulator of PR activation, holding it to an optimal timing when budding of the 
viral particles is almost complete. 
Therefore, the right content of the viral constituents is achieved. In the absence of Nef, PR 
activation would occur earlier on before the completion of budding, consequently some of 
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the protein content is lost during the formation of the viral particles, especially the IN, since 
it is one of the first enzymes to be processed out from the GagPol precursor. How would 
this explain the decreased infectivity of the Nef-deficient viruses? Since IN is important not 
only for the integration step of the viral DNA to the host genome but also participates 
during the Reverse Transcription of the viral RNA, lower concentrations of the IN would 
affect reverse transcription of the incoming virus impacting on viral infectivity. Our results 
conciliates previous data demonstrating an impairment in the HIV-1 ability to reverse 
transcribe the viral RNA genome in Nef-deficient viruses, which could not be explained by a 
role of Nef in facilitating an early step of the replication cycle as enhancement of viral capsid 
delivery to the cytosol of the target cell (Cavrois et al., 2004; Miller et al., 1995; Tobiume et 
al., 2001), trafficking of the viral cores through the cortical actin network since (Campbell 
EM, 2004; Pizzato et al., 2008), or capsid uncoating (Cavrois et al., 2004; Kotov et al., 1999). 
 




W57A Yes * 
70 
50 
(Miller et al., 1997) 
(Chen et al., 1998) 
L58A Yes 50 (Chen et al., 1998) 






(Chen et al., 1998) 
(Miller et al., 1997) 
CAW (55-57) LLL Yes ** 70 (Miller et al., 1997) 
CAW (55-57) No 
 
75 
(Miller et al., 1997) 
(Fackler et al., 2006) 
DCAWL (54-57) No 20 (Pandori et al., 1998) 
LEAQ (58-61) Yes 50 (Pandori et al., 1998) 
AWLEA (56-60) No 80 (Pandori et al., 1998) 
DCAWL (54-61)-
ATIM*** 
Yes** 30 (Pandori et al., 1998) 
Table 1. Mutations within the cleavage site of Nef and its effect on viral infectivity* Less 
cleavage of the Nef protein was observed (Miller et al., 1997). ** A higher cleavage rate of the 
Nef protein was observed (Miller et al., 1997). *** A cleavage site (ATIM) from the viral 
Nucleocapsid protein was introduced at amino acid position 55 in Nef, accelerated cleavage 
of Nef was observed (Pandori et al., 1998). 
5. Conclusion 
Nef is a multifunctional accessory protein only present in the primate lentiviruses. Its 
influence on viral infectivity and pathogenesis is undisputable. However, the mechanism by 
which Nef contributes to the optimal infectivity of these viruses is still a matter of 
controversy. The classical functions described for Nef are the downmodulation of the CD4 
and MHC-I molecules from the cell surface and the activation of signaling cascades in Nef-
expressing or HIV/SIV-infected cells. While the downmodulation of immune system 
molecules from the surface of cells, as described here, could all contribute to the effect of Nef 
on pathogenesis and disease progression, these functions failed to be correlated with the 
contribution of Nef to the optimal infectivity of HIV/SIV. Some experimental evidences 
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prompt to the conclusion that Nef participates in an early step of the replication cycle post-
entry and before reverse transcription to increase infectivity. However it is becoming more 
evident that the requirement for Nef occurs in the producer cell, possibly by modifying or 
regulating the last steps of the viral replication cycle (assembly, budding and/or 
maturation) Nef would promote the formation of optimally infectious virus progeny.  
In our model, the specific interaction of Nef with the precursor polyprotein GagPol and its 
influence on the kinetics of processing of the viral precursor proteins, predicts that in the 
absence of Nef viral PR will be activated earlier on during budding resulting in the 
incorporation of lower amounts of the viral enzymes into viral cores, especially IN. Since IN 
is crucial to the initiation of reverse transcription and that Nef-deleted viruses have a defect 
in viral DNA synthesis, our model conciliates these findings to explain the optimal 
infectivity of the viral particles in the presence of Nef.  
If that is the case, very important implications for this function of Nef in the current anti-
retroviral therapy can be predicted. First, Nef could become a target to anti-retroviral drugs 
that would act in synergism with PR inhibitors currently in use to achieve a more efficient 
inhibition of virus replication. Second, we should predict a co-evolution of both Nef and PR 
during the therapy with PR inhibitors, which will have a direct impact on the selection of 
resistance mutations that is still not appreciated.  
 
 
Fig. 2. Schematic representation of the working model for the functions of Nef during the last 
steps of the primate Lentiviral replication cycle. Nef associates with cellular membranes and 
classically exerts several functions that do not necessarily correlate with its role in increasing 
viral infectivity and promote disease progression (arrow 1). Nef from both HIV-1 and SIVmac 
binds to the p6*PR within the GagPol precursor (Costa et al., 2004; Jesus da Costa et al., 2009) 
(arrow 2). In the presence of Nef the viral PR is activated at an optimal time during the 
budding step, assuring the correct amount of the viral IN and RT inside the viral core (arrow 
3). IN influences the activity of RT during the initiation of reverse transcription, therefore the 
normal amounst of IN in viral particles will promote optimal cDNA synthesis and viral 
infectivity of the incoming viruses (arrow 4). On the other hand, in the absence of Nef viral PR 
is prematurely activated, consequently the processing of the GagPol precursor would occur 
before the formation of the viral cores leading to a lesser incorporation of IN (arrow 5), what 
would impact reverse transcription and viral infectivity  (arrow 6). 
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clinic to the patients,â€ ​ represent the unique but intertwined mission of this work: to provide basic and clinical
knowledge on HIV/AIDS.
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